Protein Therapeutics Market CAGR, Size, Share, Growth, Outlook, Demand, Key player Analysis and Opportunities till 2026

According to IMARC Group's latest report, titled "Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global protein therapeutics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Protein therapeutics are medicinal drugs utilized to treat cancer, diabetes, and neurodegenerative and other disorders. These drugs allow an individualized treatment approach by compensating for the deficiency of an essential protein. Consequently, they are gaining immense popularity around the world.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/protein-therapeutics-market/requestsample

Market Trends and Drivers:

The increasing instances of chronic diseases, in confluence with the development of plasma-derived therapies, represent one of the key factors impelling the global protein therapeutics market growth. Apart from this, governments of different countries are undertaking numerous initiatives for the development of a modernized healthcare system. This, in turn, is increasing the sales of protein therapeutics worldwide. Moreover, the rising awareness among the masses about the benefits of protein therapeutics, such as high efficiency and minimal side effects, are propelling the market growth. Furthermore, the rising cases of coronavirus disease (COVID-19) are creating a positive impact on the protein therapeutics market as they are finding is widely adopting these medicines.

Protein Therapeutics Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the protein therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Pfizer Inc.
Abbott Laboratories
Abbvie Inc.
Eli Lilly and Company
F. Hoffmann-La Roche AG (Roche Holding AG)
Amgen Inc.
Johnson & Johnson
Merck & Co. Inc.
Novo Nordisk A/S (Novo Holdings A/S)
Baxter International Inc.
Biogen Inc.
Csl Behring L.L.C. (CSL Limited)

Key Market Segmentation:

The report has segmented the global protein therapeutics market on the basis of product, therapy area, function and region.

Breakup by Product:

Monoclonal Antibodies (mAbs)
Human Insulin
Erythropoietin
Clotting Factors
Fusion Protein
Others

Breakup by Therapy Area:

Metabolic Disorders
Immunological Disorders
Hematological Disorders
Cancer
Hormonal Disorders
Genetic Disorders
Others

Breakup by Function:

Enzymatic and Regulatory Activity
Special Targeting Activity
Vaccines
Protein Diagnostics

Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2431&flag=C

Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.